Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CG Oncology (CGON) Return on Equity: 2024-2025

Historic Return on Equity for CG Oncology (CGON) over the last 2 years, with Sep 2025 value amounting to -0.22%.

  • CG Oncology's Return on Equity fell 9.00% to -0.22% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.22%, marking a year-over-year decrease of 9.00%. This contributed to the annual value of -0.29% for FY2024, which is N/A change from last year.
  • CG Oncology's Return on Equity amounted to -0.22% in Q3 2025, which was down 19.68% from -0.19% recorded in Q2 2025.
  • Over the past 5 years, CG Oncology's Return on Equity peaked at -0.11% during Q2 2024, and registered a low of -0.25% during Q1 2024.
  • Its 2-year average for Return on Equity is -0.17%, with a median of -0.15% in 2025.
  • Examining YoY changes over the last 5 years, CG Oncology's Return on Equity showed a top increase of 11bps in 2025 and a maximum decrease of 9bps in 2025.
  • Over the past 2 years, CG Oncology's Return on Equity (Quarterly) stood at -0.14% in 2024, then dropped by 9bps to -0.22% in 2025.
  • Its last three reported values are -0.22% in Q3 2025, -0.19% for Q2 2025, and -0.15% during Q1 2025.